SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-025831
Filing Date
2018-10-31
Accepted
2018-10-31 16:04:19
Documents
84
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 SRPT Q3 2018 10-Q FILING srpt-10q_20180930.htm 10-Q 3289594
2 EX-10.1 srpt-ex101_401.htm EX-10.1 100274
3 EX-10.2 srpt-ex102_402.htm EX-10.2 74951
4 EX-10.3 srpt-ex103_403.htm EX-10.3 63588
5 EX-10.4 srpt-ex104_404.htm EX-10.4 95441
6 EX-31.1 srpt-ex311_15.htm EX-31.1 10544
7 EX-31.2 srpt-ex312_9.htm EX-31.2 11125
8 EX-32.1 srpt-ex321_8.htm EX-32.1 7193
9 EX-32.2 srpt-ex322_14.htm EX-32.2 7757
  Complete submission text file 0001564590-18-025831.txt   10172920

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT srpt-20180930.xml EX-101.INS 2186224
11 XBRL TAXONOMY EXTENSION SCHEMA srpt-20180930.xsd EX-101.SCH 66468
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20180930_cal.xml EX-101.CAL 74807
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20180930_def.xml EX-101.DEF 139275
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20180930_lab.xml EX-101.LAB 429454
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20180930_pre.xml EX-101.PRE 319076
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 181150320
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences